Prostate cancer

James Mohler, Richard J. Babaian, Robert R. Bahnson, Barry Boston, Anthony D'Amico, James A. Eastham, Ralph J. Hauke, Robert P. Huben, Philip Kantoff, Mark Kawachi, Michael Kuettel, Paul H. Lange, Chris Logothetis, Gary MacVicar, Alan Pollack, Julio M. Pow-Sang, Mack Roach, Howard Sandler, Dennis Shrieve, Sandhya SrinivasPrzemyslaw Twardowski, Donald A. Urban, Patrick Walsh

Research output: Contribution to journalArticle

Abstract

The intention of the NCCN Prostate Cancer Guidelines is to provide a framework on which to base treatment decisions. Prostate cancer is a complex disease, with many controversial aspects of management and with a dearth of sound data to support treatment recommendations. Several variables (including life expectancy, disease characteristics, predicted outcomes, and patient preferences) must be considered by the patient and physician in tailoring prostate cancer therapy to the individual patient.

Original languageEnglish (US)
Pages (from-to)650-683
Number of pages34
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume5
Issue number7
StatePublished - Aug 2007
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Patient Preference
Life Expectancy
Therapeutics
Guidelines
Physicians

Keywords

  • Biopsy active surveillance
  • Carcinoma screening
  • Early detection
  • Life expectancy estimation
  • NCCN Clinical Practice Guidelines
  • Prostate cancer
  • Prostate-specific antigen
  • Robot-assisted laparoscopic radical prostatectomy

ASJC Scopus subject areas

  • Oncology

Cite this

Mohler, J., Babaian, R. J., Bahnson, R. R., Boston, B., D'Amico, A., Eastham, J. A., ... Walsh, P. (2007). Prostate cancer. JNCCN Journal of the National Comprehensive Cancer Network, 5(7), 650-683.

Prostate cancer. / Mohler, James; Babaian, Richard J.; Bahnson, Robert R.; Boston, Barry; D'Amico, Anthony; Eastham, James A.; Hauke, Ralph J.; Huben, Robert P.; Kantoff, Philip; Kawachi, Mark; Kuettel, Michael; Lange, Paul H.; Logothetis, Chris; MacVicar, Gary; Pollack, Alan; Pow-Sang, Julio M.; Roach, Mack; Sandler, Howard; Shrieve, Dennis; Srinivas, Sandhya; Twardowski, Przemyslaw; Urban, Donald A.; Walsh, Patrick.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 5, No. 7, 08.2007, p. 650-683.

Research output: Contribution to journalArticle

Mohler, J, Babaian, RJ, Bahnson, RR, Boston, B, D'Amico, A, Eastham, JA, Hauke, RJ, Huben, RP, Kantoff, P, Kawachi, M, Kuettel, M, Lange, PH, Logothetis, C, MacVicar, G, Pollack, A, Pow-Sang, JM, Roach, M, Sandler, H, Shrieve, D, Srinivas, S, Twardowski, P, Urban, DA & Walsh, P 2007, 'Prostate cancer', JNCCN Journal of the National Comprehensive Cancer Network, vol. 5, no. 7, pp. 650-683.
Mohler J, Babaian RJ, Bahnson RR, Boston B, D'Amico A, Eastham JA et al. Prostate cancer. JNCCN Journal of the National Comprehensive Cancer Network. 2007 Aug;5(7):650-683.
Mohler, James ; Babaian, Richard J. ; Bahnson, Robert R. ; Boston, Barry ; D'Amico, Anthony ; Eastham, James A. ; Hauke, Ralph J. ; Huben, Robert P. ; Kantoff, Philip ; Kawachi, Mark ; Kuettel, Michael ; Lange, Paul H. ; Logothetis, Chris ; MacVicar, Gary ; Pollack, Alan ; Pow-Sang, Julio M. ; Roach, Mack ; Sandler, Howard ; Shrieve, Dennis ; Srinivas, Sandhya ; Twardowski, Przemyslaw ; Urban, Donald A. ; Walsh, Patrick. / Prostate cancer. In: JNCCN Journal of the National Comprehensive Cancer Network. 2007 ; Vol. 5, No. 7. pp. 650-683.
@article{392dc07e57d24c6e820a58e7ce539b6f,
title = "Prostate cancer",
abstract = "The intention of the NCCN Prostate Cancer Guidelines is to provide a framework on which to base treatment decisions. Prostate cancer is a complex disease, with many controversial aspects of management and with a dearth of sound data to support treatment recommendations. Several variables (including life expectancy, disease characteristics, predicted outcomes, and patient preferences) must be considered by the patient and physician in tailoring prostate cancer therapy to the individual patient.",
keywords = "Biopsy active surveillance, Carcinoma screening, Early detection, Life expectancy estimation, NCCN Clinical Practice Guidelines, Prostate cancer, Prostate-specific antigen, Robot-assisted laparoscopic radical prostatectomy",
author = "James Mohler and Babaian, {Richard J.} and Bahnson, {Robert R.} and Barry Boston and Anthony D'Amico and Eastham, {James A.} and Hauke, {Ralph J.} and Huben, {Robert P.} and Philip Kantoff and Mark Kawachi and Michael Kuettel and Lange, {Paul H.} and Chris Logothetis and Gary MacVicar and Alan Pollack and Pow-Sang, {Julio M.} and Mack Roach and Howard Sandler and Dennis Shrieve and Sandhya Srinivas and Przemyslaw Twardowski and Urban, {Donald A.} and Patrick Walsh",
year = "2007",
month = "8",
language = "English (US)",
volume = "5",
pages = "650--683",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "7",

}

TY - JOUR

T1 - Prostate cancer

AU - Mohler, James

AU - Babaian, Richard J.

AU - Bahnson, Robert R.

AU - Boston, Barry

AU - D'Amico, Anthony

AU - Eastham, James A.

AU - Hauke, Ralph J.

AU - Huben, Robert P.

AU - Kantoff, Philip

AU - Kawachi, Mark

AU - Kuettel, Michael

AU - Lange, Paul H.

AU - Logothetis, Chris

AU - MacVicar, Gary

AU - Pollack, Alan

AU - Pow-Sang, Julio M.

AU - Roach, Mack

AU - Sandler, Howard

AU - Shrieve, Dennis

AU - Srinivas, Sandhya

AU - Twardowski, Przemyslaw

AU - Urban, Donald A.

AU - Walsh, Patrick

PY - 2007/8

Y1 - 2007/8

N2 - The intention of the NCCN Prostate Cancer Guidelines is to provide a framework on which to base treatment decisions. Prostate cancer is a complex disease, with many controversial aspects of management and with a dearth of sound data to support treatment recommendations. Several variables (including life expectancy, disease characteristics, predicted outcomes, and patient preferences) must be considered by the patient and physician in tailoring prostate cancer therapy to the individual patient.

AB - The intention of the NCCN Prostate Cancer Guidelines is to provide a framework on which to base treatment decisions. Prostate cancer is a complex disease, with many controversial aspects of management and with a dearth of sound data to support treatment recommendations. Several variables (including life expectancy, disease characteristics, predicted outcomes, and patient preferences) must be considered by the patient and physician in tailoring prostate cancer therapy to the individual patient.

KW - Biopsy active surveillance

KW - Carcinoma screening

KW - Early detection

KW - Life expectancy estimation

KW - NCCN Clinical Practice Guidelines

KW - Prostate cancer

KW - Prostate-specific antigen

KW - Robot-assisted laparoscopic radical prostatectomy

UR - http://www.scopus.com/inward/record.url?scp=34547952464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547952464&partnerID=8YFLogxK

M3 - Article

C2 - 17692170

AN - SCOPUS:34547952464

VL - 5

SP - 650

EP - 683

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 7

ER -